References
- Skodlar B, Tomori M, Parnas J. Subjective experience and suicidal ideation in schizophrenia. Compr Psychiatry. 2008;49:482–488.
- Nordentoft M, Madsen T, Fedyszyn I. Suicidal behavior and mortality in first-episode psychosis. J Nerv Ment Dis. 2015;203:387–392.
- Flanagan RJ. Fatal toxicity of drugs used in psychiatry. Hum Psychopharmacol. 2008;23:S43–S51.
- Thompson C. The use of high-dose antipsychotic medication. Br J Psychiatry. 1994;164:448–458.
- Reilly JG, Ayis SA, Ferrier IN, et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000;355:1048–1052.
- Reilly JG, Ayis SA, Ferrier IN, et al. Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry. 2002;180:515–522.
- Witchel HJ, Hancox JC, Nutt DJ. Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol. 2003;23:58–77.
- MHRA. Medicines and Healthcare Products Regulatory Agency (medicines) restricts the use of thioridazine. Press release 2000/0734. London: Medicines and Healthcare Products Regulatory Agency; 2000.
- Ray WA, Meador KG. Antipsychotics and sudden death: is thioridazine the only bad actor? Br J Psychiatry. 2002;180:483–484.
- Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225–235. (Erratum: N Engl J Med 2009; 361: 1814.)
- Handley SA, Flanagan RJ . Drugs and other chemicals involved in fatal poisoning in England and Wales during 2000–2011. Clin Toxicol (Phila). 2014;52:1–12.
- Griffiths C, Flanagan RJ. Fatal poisoning with antipsychotic drugs, England and Wales 1993–2002. J Psychopharmacol (Oxford). 2005;19:667–674.
- Office for National Statistics. Deaths related to drug poisoning in England and Wales, 2013. Statistical Bulletin. 3 September; [cited 2015 June 6]. Available from: http://www.ons.gov.uk/ons/dcp171778_375498.pdf.
- British National Formulary. Edition 69. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain; 2015.
- Office for National Statistics. Mid-1971 to mid-2012 population estimates: quinary age groups for constituent countries in the United Kingdom; estimated resident population. Reference Table. 17 December 2013; [cited 2015 June 8]. Available from: http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk–england-and-wales–scotland-and-northern-ireland/population-estimates-timeseries-1971-to-current-year/index.html.
- Office for National Statistics. Annual Mid-year Population Estimates, 2013. Reference Table. 26 June; [cited 2015 June 8]. Available from: http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk–england-and-wales–scotland-and-northern-ireland/2013/index.html
- Heath and Social Care Information Centre. [cited 2015 June 8]. Available from: www.hscic.gov.uk/
- Welsh Government. [cited 2015 June 8]. Available from: http://gov.wales/statistics-and-research/prescriptions-dispensed-community/?lang=en#/statistics-and-research/prescriptions-dispensed-community/?tab=previous&lang=en
- Adelstein A, Mardon C. Suicides 1961–74. Popul Trends. 1975;2:13–18.
- Flanagan RJ, Spencer EP, Morgan PE, et al. Suspected clozapine poisoning in the UK/Eire, 1992–2003. Forensic Sci Int. 2005;155:91–99.
- Fisher DS, Partridge SJ, Handley SA, et al. Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum. Forensic Sci Int. 2013;229:151–156.
- Baselt RC. Disposition of toxic drugs and chemicals in man. 10th ed. Seal Beach (CA): Biomedical Publications; 2014.
- Pokorny R, Finkel MJ, Robinson WT. Normal volunteers should not be used for bioavailability or bioequivalence studies of clozapine. Pharm Res. 1994;11:1221.
- MacCall C, Billcliff N, Igbrude W, et al. Clozapine: more than 900 mg/day may be needed. J. Psychopharmacol (Oxford). 2009;23:206–210.
- Buckley N, McManus P. Fatal toxicity of drugs used in the treatment of psychotic illnesses. Br J Psychiatry. 1998;172:461–464.
- Marston L, Nazareth I, Petersen I, et al. Prescribing of antipsychotics in UK primary care: a cohort study. BMJ Open. 2014;4:e006135.
- Verdoux H, Tournier M, Begaud B. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand. 2010;121:4–10.
- Patel MX, Bishara D, Jayakumar S, et al. Quality of prescribing for schizophrenia: evidence from a national audit in England and Wales. Eur Neuropsychopharmacol. 2014;24:499–509.
- Wright NMJ, Roberts AJ, Allgar VL, et al. Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis. Br J Gen Pract. 2004;54:370–373.
- Ilyas S, Moncrieff J. Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010. Br J Psychiatry. 2012;200:393–398.
- Capel MM, Colbridge MG, Henry JA. Overdose profiles of new antipsychotic agents. Int J Neuropsychopharmacol. 2000;3:51–54.
- Singh LK, Praharaj SK, Sahu M. Nonfatal suicidal overdose of olanzapine in an adolescent. Curr Drug Saf. 2012;7:328–329.
- Palenzona S, Meier PJ, Kupferschmidt H, et al. The clinical picture of olanzapine poisoning with special reference to fluctuating mental status. Clin Toxicol. 2004;42:27–32.
- Lennestål R, Asplund C, Nilsson M, et al. Serum levels of olanzapine in a non-fatal overdose. J Anal Toxicol. 2007;31:119–121.
- Tse GH, Warner MH, Waring WS. Prolonged toxicity after massive olanzapine overdose: two cases with confirmatory laboratory data. J Toxicol Sci. 2008;33:363--365.
- Elian AA . Fatal overdose of olanzepine. Forensic Sci Int. 1998;91:231–235.
- Stephens BG, Coleman DE, Baselt RC. Olanzapine-related fatality. J Forensic Sci. 1998;43:1252–1253.
- Gerber JE, Cawthon B. Overdose and death with olanzapine: two case reports. Am J Forensic Med Pathol. 2000;21:249–251.
- Schreinzer D, Frey R, Stimpfl T, et al. Different fatal toxicity of neuroleptics identified by autopsy. Eur Neuropsychopharmacol. 2001;11:117–124.
- Merrick TC, Felo JA, Jenkins AJ. Tissue distribution of olanzapine in a postmortem case. Am J Forensic Med Pathol. 2001;22:270–274.
- Chue P, Singer P. A review of olanzapine-associated toxicity and fatality in overdose. J Psychiatry Neurosci. 2003;28:253–261.
- Davis LE, Becher MW, Tlomak W, et al. Persistent choreoathetosis in a fatal olanzapine overdose: drug kinetics, neuroimaging, and neuropathology. Am J Psychiatry. 2005;162:28–33.
- Berling I, Isbister GK. Prolonged QT risk assessment in antipsychotic overdose using the QT nomogram. Ann Emerg Med. 2015;66:154–164.
- Isbister GK, Murray L, John S, et al. Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes. Med J Aust. 2006;184:354–356.
- Flanagan RJ. Poisoning: fact or fiction? Med Leg J. 2012;80:127–148.
- Malekshahi T, Tioleco N, Ahmed N, et al. Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse. J Subst Abuse Treat. 2015;48:8–12.
- Pilgrim JL, Drummer OH. The toxicology and comorbidities of fatal cases involving quetiapine. Forensic Sci Med Pathol. 2013;9:170–176.
- Vivek S. No QT interval prolongation associated with quetiapine overdose. Am J Emerg Med. 2004;22:330.
- Hunfeld NG, Westerman EM, Boswijk DJ, et al. Quetiapine in overdosage: a clinical and pharmacokinetic analysis of 14 cases. Ther Drug Monit. 2006;28:185–189.
- Balit CR, Isbister GK, Hackett LP, et al. Quetiapine poisoning: a case series. Ann Emerg Med. 2003;42:751–758.
- Reichert C, Reichert P, Monnet-Tschudi F, et al. Seizures after single-agent overdose with pharmaceutical drugs: analysis of cases reported to a poison center. Clin Toxicol (Phila). 2014;52:629–634.
- Mainland MK, Wagner MA, Gock SB, et al. Quetiapine-related fatalities. J Anal Toxicol. 2001;25:381–382.
- Fernandes PP, Marcil WA. Death associated with quetiapine overdose. Am J Psychiatry. 2002;159:2114.
- Trenton A, Currier G, Zwemer F. Fatalities associated with therapeutic use and overdose of atypical antipsychotics. CNS Drugs. 2003;17:307–324.
- Hopenwasser J, Mozayani A, Danielson TJ, et al. Postmortem distribution of the novel antipsychotic drug quetiapine. J Anal Toxicol. 2004;28:264–267.
- Langman LJ, Kaliciak HA, Carlyle S. Fatal overdoses associated with quetiapine. J Anal Toxicol. 2004;28:520–525.
- Hasnain M, Vieweg WV, Howland RH, et al. Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports. Ther Adv Psychopharmacol. 2014;4:130–138.
- Aguilar EJ, Siris SG. Do antipsychotic drugs influence suicidal behavior in schizophrenia? Psychopharmacol Bull. 2007;40:128–142.